Concepedia

Erik Wagner

EW

Statistics

Publications

18

Citations

1.5K

H-Index

17

Active since

1995

Affiliations

Princeton University(Current)

Pearl River Community College

Women's Health Research Institute

Arqule (United States)

Albany Molecular Research (United States)

Erik Wagner is an author at Princeton University specializing in drug discovery, medicine, and pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryBiochemistryMedicinal ChemistryNatural SciencesMolecular PharmacologyChemical BiologyDrug DevelopmentPharmacotherapy

Publications per year

1995–2010

18

Publications

18

Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels

David Riddell, Hua Zhou, Kevin Atchison et al. · Journal of Neuroscience · 2008 · 343 citations · Full text

Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer’s Disease

Robert Martone, Hua Zhou, Kevin Atchison et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 157 citations

Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascade

J. Steven Jacobsen, Thomas A. Comery, Robert Martone et al. · Proceedings of the National Academy of Sciences · 2008 · 136 citations · Full text

Neurochemical Biomarkers, Social Sciences, Enhanced Clearance +21

Design and Synthesis of 5,5′-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors

Michael S. Malamas, Jim Erdei, Iwan Gunawan et al. · Journal of Medicinal Chemistry · 2009 · 133 citations · Full text

Drug Target, 5,5′-Disubstituted Aminohydantoins, Chemical Biology +17

Aminoimidazoles as Potent and Selective Human β-Secretase (BACE1) Inhibitors

Michael S. Malamas, Jim Erdei, Iwan Gunawan et al. · Journal of Medicinal Chemistry · 2009 · 113 citations · Full text

Small Molecule Aminoimidazoles, Drug Target, Pharmacotherapy +18

1–5 of 18